home site map contact us
About Deltagen
Target Drug Discovery and Validation
Drug Discovery
Drug Metabolism
Preclinical Development
Investor Relations

Deltagen, Inc.
Deltagen is a leading provider of drug discovery tools and services to the biopharmaceutical industry. Deltagen offers a suite of programs designed to enhance the efficiency of drug discovery including access to biological models as well as both small-molecule and secreted protein drug targets. In addition, Deltagen offers extensive target validation data in the areas of immunology and metabolic diseases. Deltagen's products and programs have been validated by customers and partners such as Eli Lilly & Co., GlaxoSmithKline, Merck & Co., Millennium Pharmaceuticals and Pfizer.

©2010 Deltagen, Inc. All rights reserved.